4 Stocks To Watch When Apple Launches New iPhone At ‘Far Out’ Event

Apple Inc (NASDAQ: AAPL) is expected to debut its iPhone 14 lineup, and its new Apple Watch lineup at the company’s annual September launch event dubbed “Far Out” on Wednesday. The product release will take place at the Steve Jobs Theater at Apple’s headquarters in Cupertino, California, and will be broadcast live on the company’s […]

Indian Car Service Firm Seeks $35M Capital Infusion From SoftBank: Report

SoftBank Group Corp (OTC: SFTBY) might invest $35 million in Indian car service and repair firm GoMechanic, Reuters reported. SoftBank has been in discussions with GoMechanic for more than nine months and was initially uncomfortable with the Indian firm’s valuation request of $1 billion. Vision Fund’s early-stage talks with GoMechanic are being … Full story available on […]

EQT Corp Close To Buying THQ Appalachia: Report

U.S.-based natural gas producer EQT Corporation (NYSE: EQT) is in advanced talks to purchase exploration and production company THQ Appalachia I (THQA) for approximately $4 billion, including debt, reported Reuters, citing people familiar with the matter. Backed by Tug Hill Operating and Quantum Energy Partners, THQ Appalachia I focuses on assets in the Marcellus, Utica/Point Pleasant, and Upper Devonian plays in […]

Oregon’s Psychedelics Law Comes Down To Individuals: Which Counties Will Ban Them?

Measure 109 is Oregon’s 2020 statewide ballot that provides the framework for the rollout of psilocybin services. While they are set to commence in January 2023, the measure also gives counties the possibility to opt-out of the initiative. The measure had the initial support of 56% of total state voters. Cities and counties had until […]

As DEA Withdraws In Psychedelics Battle Over DOI And DOC, Researchers Win – For Now

The Drug Enforcement Administration (DEA) is pulling back efforts to list certain hallucinogens as Schedule I substances after being challenged by scientists. “DOI and DOC are incredible tools for research, as well as mental and physical health,” Panacea Plant Sciences CEO David Heldreth told Marijuana Moment. Heldreth was referring to dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). […]

What Psychiatrists Think Of Current US Psychedelics Policies

Psychiatrists differ considerably in their perceptions of certain psychedelic substances. That’s according to a new report from Ohio State University, in which 181 doctors took part in a survey about psychedelic safety and therapeutic value, as well as how they are categorized under U.S. policy. These substances were originally classified in 1970, following the Controlled […]

Merck’s Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report

Merck & Co Inc (NYSE: MRK) and Seagen Inc (NASDAQ: SGEN) have not been able to agree on a buyout price, Bloomberg reported. The deal talks have been stalled, for now, threatening Merck’s potentially the largest deal in more than a decade, according to people familiar with the matter. Previously, Merck and Seagen’s deal was expected to be sealed […]

Owl Creek Urges Cano Health Board To Consider Potential Sale

Owl Creek Asset Management L.P. sent a letter to Cano Health Inc (NYSE: CANO) board strongly encouraging the company to pursue strategic alternatives, including a potential sale. Owl Creek owns around a 3.75% stake in Cano. According to the letter, the asset management says, “the past year’s roller coaster of accounting issues has shaken our confidence. We feel that […]